Israeli-based Compugen Achieves FDA IND Clearance & Commences Site Selection in America for Immune-oncology Therapeutic Antibody
Israel-based Compugen, Ltd. (CGEN), a clinical-stage cancer immunotherapy company positioned as a leader in predictive target therapy reported that the […]
